David Wu is a Respiratory physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
30701 Woodward Ave Ste 200
Royal Oak, MI 480730990
Telephone
248-548-2114Provider last certified this registry record 12 Sept 2024.
Industry payments
40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Verona Pharma, Inc.Program year202528 payments
- GlaxoSmithKline, LLC.Program year202525 payments
- AstraZeneca Pharmaceuticals LPProgram year202514 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
77.4%Corticosteroid41.7%Trelegy Ellipta45%Breo Ellipta15%Breztri Aerosphere13%Symbicort11%Fluticasone Propionate6%Arnuity Ellipta4%Fluticasone-Vilanterol4%Budesonide-Formoterol Fumarate3%Part D<11 patientsbeta2-Adrenergic Agonist30.2%Albuterol Sulfate Hfa85%Ventolin Hfa15%Part D≥88 patients+ 3 more classes in this area
Metabolism & gastrointestinal
8.8%Corticosteroid8.8%Prednisone100%Part D≥39 patientsDermatology
4.8%Corticosteroid4.8%Methylprednisolone100%Part D≥33 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”